Chapter 1.Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Erythropoietin Drugs Market, by Drug Class, 2019-2027 (USD Billion)
1.2.2. Erythropoietin Drugs Market, by Product, 2019-2027 (USD Billion)
1.2.3. Erythropoietin Drugs Market, by Application, 2019-2027 (USD Billion)
1.2.4. Erythropoietin Drugs Market, by, 2019-2027 (USD Billion)
1.2.5. Erythropoietin Drugs Market, by, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Erythropoietin Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Erythropoietin Drugs Market Dynamics
3.1. Erythropoietin Drugs Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing demand from patients of HIV and kidney Diseases
3.1.1.2. Rising incidence of diabetes and heart diseases
3.1.2. Market Challenges
3.1.2.1. High cost of production of drugs
3.1.3. Market Opportunities
3.1.3.1. Patent expiration of major drug manufacturers
Chapter 4. Global Erythropoietin Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Erythropoietin Drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Erythropoietin Drugs Market by Drug Class, Performance - Potential Analysis
5.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
5.4. Erythropoietin Drugs Market, Sub Segment Analysis
5.4.1. Biologics
5.4.2. Biosimilars
Chapter 6. Global Erythropoietin Drugs Market, by Product
6.1. Market Snapshot
6.2. Global Erythropoietin Drugs Market by Product, Performance - Potential Analysis
6.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
6.4. Erythropoietin Drugs Market, Sub Segment Analysis
6.4.1. Epoetin-alfa
6.4.2. Epoetin-beta
6.4.3. Darbepoetin-alfa
6.4.4. Others
Chapter 7. Global Erythropoietin Drugs Market, by Application
7.1. Market Snapshot
7.2. Global Erythropoietin Drugs Market by Application, Performance - Potential Analysis
7.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Erythropoietin Drugs Market, Sub Segment Analysis
7.4.1. Cancer
7.4.2. Haematology
7.4.3. Renal Diseases
7.4.4. Neurology
Chapter 8. Global Erythropoietin Drugs Market, Regional Analysis
8.1. Erythropoietin Drugs Market, Regional Market Snapshot
8.2. North America Erythropoietin Drugs Market
8.2.1. U.S. Erythropoietin Drugs Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
8.2.1.2. Product breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Erythropoietin Drugs Market
8.3. Europe Erythropoietin Drugs Market Snapshot
8.3.1. U.K. Erythropoietin Drugs Market
8.3.2. Germany Erythropoietin Drugs Market
8.3.3. France Erythropoietin Drugs Market
8.3.4. Spain Erythropoietin Drugs Market
8.3.5. Italy Erythropoietin Drugs Market
8.3.6. Rest of Europe Erythropoietin Drugs Market
8.4. Asia-Pacific Erythropoietin Drugs Market Snapshot
8.4.1. China Erythropoietin Drugs Market
8.4.2. India Erythropoietin Drugs Market
8.4.3. Japan Erythropoietin Drugs Market
8.4.4. Australia Erythropoietin Drugs Market
8.4.5. South Korea Erythropoietin Drugs Market
8.4.6. Rest of Asia Pacific Erythropoietin Drugs Market
8.5. Latin America Erythropoietin Drugs Market Snapshot
8.5.1. Brazil Erythropoietin Drugs Market
8.5.2. Mexico Erythropoietin Drugs Market
8.6. Rest of The World Erythropoietin Drugs Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Johnson & Johnson
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Celltrion, Inc.
9.2.3. Teva Pharmaceutical Industries Ltd
9.2.4. Amgen, Inc.
9.2.5. Hoffman-La Roche Ltd.
9.2.6. LG Life Sciences Ltd.
9.2.7. Biocon Limited
9.2.8. Intas Pharmaceuticals Ltd.
9.2.9. Sun Pharmaceutical Industries Ltd.
9.2.10. Dr. Reddy's Laboratories Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption